AC
BSX icon

Avestar Capital’s Boston Scientific BSX Stock Holding History

Avestar Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Sell
15,051
-1,724
-10% -$93.6K 0.04% 321
2026
Q1 		$1.05M Buy
16,775
+1,738
+12% +$139K 0.07% 214
2025
Q4 		$1.43M Sell
15,037
-501
-3% -$49.1K 0.09% 164
2025
Q3 		$1.52M Sell
15,538
-2,693
-15% -$279K 0.1% 157
2025
Q2 		$1.96M Buy
18,231
+1,332
+8% +$135K 0.13% 120
2025
Q1 		$1.7M Sell
16,899
-482
-3% -$48.5K 0.15% 120
2024
Q4 		$1.55M Buy
17,381
+4,984
+40% +$439K 0.13% 125
2024
Q3 		$1.04M Buy
12,397
+1,158
+10% +$91.3K 0.11% 149
2024
Q2 		$866K Sell
11,239
-1,122
-9% -$82.1K 0.09% 169
2024
Q1 		$847K Buy
12,361
+2,074
+20% +$133K 0.09% 171
2023
Q4 		$595K Buy
10,287
+892
+9% +$47.6K 0.07% 177
2023
Q3 		$496K Buy
9,395
+20
+0.2% +$1.05K 0.07% 170
2023
Q2 		$507K Buy
9,375
+1,033
+12% +$54K 0.08% 149
2023
Q1 		$417K Buy
8,342
+560
+7% +$26.4K 0.07% 167
2022
Q4 		$360K Sell
7,782
-225
-3% -$9.74K 0.07% 180
2022
Q3 		$310K Sell
8,007
-680
-8% -$27.3K 0.08% 176
2022
Q2 		$324K Buy
8,687
+1,936
+29% +$78.8K 0.08% 194
2022
Q1 		$299K Buy
6,751
+408
+6% +$17.7K 0.05% 315
2021
Q4 		$269K Buy
6,343
+1,026
+19% +$43.1K 0.03% 368
2021
Q3 		$231K Buy
5,317
+148
+3% +$6.55K 0.03% 398
2021
Q2 		$221K Buy
+5,169
New +$217K 0.03% 400
2019
Q3 		– Sell
-159
Closed -$5K – 262
2019
Q2 		$5K Hold
159
– – ﹤0.01% 576
2019
Q1 		$4K Hold
159
– – ﹤0.01% 587
2018
Q4 		$4K Hold
159
– – ﹤0.01% 551
2018
Q3 		$4K Sell
159
-4
-2% -$140 ﹤0.01% 564
2018
Q2 		$2K Sell
163
-22
-12% -$664 ﹤0.01% 666
2018
Q1 		$3K Buy
185
+29
+19% +$788 ﹤0.01% 590
2017
Q4 		$2K Buy
+156
New +$4.3K ﹤0.01% 617

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Avestar Capital's BSX Position: Q2 2026 in Review

Avestar Capital reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $93.6K and leaving 15,051 shares worth $642K. The position accounts for 0.04% of the portfolio, ranked #321.

Avestar Capital first reported a position in BSX in Q4 2017 and has held it in 28 quarters since. The position peaked at $1.96M in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Avestar Capital held 15,051 shares of Boston Scientific worth $642K as of Q2 2026.
  • Avestar Capital sold 1,724 Boston Scientific shares in Q2 2026, an estimated $93.6K.
  • Boston Scientific made up 0.04% of Avestar Capital's portfolio in Q2 2026, its #321 holding.
  • Avestar Capital first reported a position in Boston Scientific in Q4 2017 and has held it in 28 quarters since.
  • Avestar Capital's Boston Scientific position peaked at $1.96M in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.